ULTANE

Adverse Events

Drug Profile

Learn More

Reference

About Results

Comments

Ultane Adverse Events Reported to the FDA Over Time

How are Ultane adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Ultane, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Ultane is flagged as the suspect drug causing the adverse event.

Most Common Ultane Adverse Events Reported to the FDA

What are the most common Ultane adverse events reported to the FDA?

Anaesthetic Complication	72 (15.58%)
Hyperthermia Malignant	16 (3.46%)
Unwanted Awareness During Anaesthes...	11 (2.38%)
Cardiac Arrest	9 (1.95%)
Hypotension	9 (1.95%)
Bronchospasm	8 (1.73%)
Convulsion	8 (1.73%)
Bradycardia	7 (1.52%)
Post Procedural Complication	7 (1.52%)
Pulmonary Oedema	7 (1.52%)
Aggression	6 (1.3%)
	Show More
Hepatitis	6 (1.3%)
Laryngospasm	6 (1.3%)
Metabolic Acidosis	6 (1.3%)
Drug Toxicity	5 (1.08%)
Accidental Exposure	4 (.87%)
Amnesia	4 (.87%)
Anaesthetic Complication Neurologic...	4 (.87%)
Confusional State	4 (.87%)
Dyskinesia	4 (.87%)
Premature Recovery From Anaesthesia	4 (.87%)
Pulmonary Haemorrhage	4 (.87%)
Blood Pressure Increased	3 (.65%)
Burning Sensation	3 (.65%)
Compartment Syndrome	3 (.65%)
Cough	3 (.65%)
Crepitations	3 (.65%)
Cyanosis	3 (.65%)
Delayed Recovery From Anaesthesia	3 (.65%)
Drug Abuse	3 (.65%)
Drug Interaction	3 (.65%)
Heart Rate Increased	3 (.65%)
Hepatitis Cholestatic	3 (.65%)
Hypertension	3 (.65%)
Jaundice	3 (.65%)
Light Anaesthesia	3 (.65%)
Multi-organ Failure	3 (.65%)
Muscular Weakness	3 (.65%)
Obstructive Airways Disorder	3 (.65%)
Overdose	3 (.65%)
Rhabdomyolysis	3 (.65%)
Acute Hepatic Failure	2 (.43%)
Airway Burns	2 (.43%)
Anaphylactic Reaction	2 (.43%)
Apnoea	2 (.43%)
Arrhythmia	2 (.43%)
Aspartate Aminotransferase Increase...	2 (.43%)
Atelectasis	2 (.43%)
Cardiac Procedure Complication	2 (.43%)
Coma Hepatic	2 (.43%)
Device Malfunction	2 (.43%)
Drug Effect Prolonged	2 (.43%)
Drug Ineffective	2 (.43%)
Fluorosis	2 (.43%)
Generalised Erythema	2 (.43%)
Grand Mal Convulsion	2 (.43%)
Hepatic Failure	2 (.43%)
Hepatic Necrosis	2 (.43%)
Hepatotoxicity	2 (.43%)
Hyperkalaemia	2 (.43%)
Hypoxia	2 (.43%)
Iatrogenic Injury	2 (.43%)
Increased Bronchial Secretion	2 (.43%)
Loss Of Consciousness	2 (.43%)
Malaise	2 (.43%)
Medication Error	2 (.43%)
Muscle Rigidity	2 (.43%)
Nausea	2 (.43%)
Pain	2 (.43%)
Paresis	2 (.43%)
Pco2 Increased	2 (.43%)
Post Procedural Haemorrhage	2 (.43%)
Procedural Complication	2 (.43%)
Rash	2 (.43%)
Skin Discolouration	2 (.43%)
Somnolence	2 (.43%)
Suicide Attempt	2 (.43%)
Supraventricular Tachycardia	2 (.43%)
Tachycardia	2 (.43%)
Thermal Burn	2 (.43%)
Tonic Clonic Movements	2 (.43%)
Troponin Increased	2 (.43%)
Ventricular Tachycardia	2 (.43%)
Weight Decreased	2 (.43%)
Acidosis	1 (.22%)
Acute Pulmonary Oedema	1 (.22%)
Airway Complication Of Anaesthesia	1 (.22%)
Alanine Aminotransferase Increased	1 (.22%)
Anaemia	1 (.22%)
Anaphylactic Shock	1 (.22%)
Anaphylactoid Reaction	1 (.22%)
Anticholinergic Syndrome	1 (.22%)
Anxiety	1 (.22%)
Atrial Fibrillation	1 (.22%)
Biopsy Liver Abnormal	1 (.22%)
Blood Bilirubin Increased	1 (.22%)
Blood Creatine Phosphokinase Increa...	1 (.22%)
Blood Lactate Dehydrogenase Increas...	1 (.22%)
Blood Pressure Decreased	1 (.22%)
Body Temperature Increased	1 (.22%)
Brain Injury	1 (.22%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Ultane, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ultane is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Ultane

What are the most common Ultane adverse events reported to the FDA?

Procedural And Device Related Injur...	114 (24.68%)
Cardiac Arrhythmias	27 (5.84%)
Hepatic And Hepatobiliary	23 (4.98%)
Respiratory	21 (4.55%)
Body Temperature Conditions	16 (3.46%)
Neurological	16 (3.46%)
Muscle	15 (3.25%)
Seizures	13 (2.81%)
Bronchial Disorders	12 (2.6%)
Decreased And Nonspecific Blood Pre...	11 (2.38%)
Lower Respiratory Tract Disorders	11 (2.38%)
	Show More
Movement Disorders	10 (2.16%)
Cardiac And Vascular Investigations	9 (1.95%)
Medication Errors	9 (1.95%)
Epidermal And Dermal Conditions	8 (1.73%)
Hepatobiliary	8 (1.73%)
Acid-base	7 (1.52%)
Chemical Injury And Poisoning	7 (1.52%)
Therapeutic And Nontherapeutic Effe...	7 (1.52%)
Deliria	6 (1.3%)
Injuries	6 (1.3%)
Personality Disorders	6 (1.3%)
Upper Respiratory Tract Disorders	6 (1.3%)
Mental Impairment	5 (1.08%)
Allergic Conditions	4 (.87%)
Enzyme	4 (.87%)
Injuries By Physical Agents	4 (.87%)
Metabolic, Nutritional And Blood Ga...	4 (.87%)
Cardiac Disorder Signs	3 (.65%)
Gastrointestinal Signs	3 (.65%)
Hematology Investigations	3 (.65%)
Physical Examination Topics	3 (.65%)
Psychiatric	3 (.65%)
Suicidal And Self-injurious Behavio...	3 (.65%)
Therapeutic Procedures And Supporti...	3 (.65%)
Vascular Hypertensive	3 (.65%)
Electrolyte And Fluid Balance Condi...	2 (.43%)
Fungal Infectious	2 (.43%)
Gastrointestinal Motility And Defec...	2 (.43%)
Vascular Hemorrhagic	2 (.43%)
Anemias Nonhemolytic And Marrow Dep...	1 (.22%)
Anxiety Disorders	1 (.22%)
Bladder And Bladder Neck Disorders	1 (.22%)
Bone Disorders	1 (.22%)
Central Nervous System Vascular	1 (.22%)
Changes In Physical Activity	1 (.22%)
Fatal Outcomes	1 (.22%)
Gallbladder	1 (.22%)
Gastrointestinal Hemorrhages	1 (.22%)
Gastrointestinal Stenosis And Obstr...	1 (.22%)
Glucose Metabolism Disorders	1 (.22%)
Headaches	1 (.22%)
Hematological And Lymphoid Tissue T...	1 (.22%)
Infections - Pathogen Unspecified	1 (.22%)
Iron And Trace Metal Metabolism	1 (.22%)
Myocardial	1 (.22%)
Neuromuscular	1 (.22%)
Ocular Sensory Symptoms	1 (.22%)
Peritoneal And Retroperitoneal Cond...	1 (.22%)
Protein And Chemistry Analyses	1 (.22%)
Psychiatric And Behavioural Symptom...	1 (.22%)
Renal And Urinary Tract Investigati...	1 (.22%)
Salivary Gland Conditions	1 (.22%)
Structural Brain	1 (.22%)
Urinary Tract Signs	1 (.22%)
White Blood Cell	1 (.22%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Ultane, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ultane is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Ultane According to Those Reporting Adverse Events

Why are people taking Ultane, according to those reporting adverse events to the FDA?

Anaesthesia	68
Adenoidectomy	24
Drug Use For Unknown Indication	21
Myringotomy	17
Induction Of Anaesthesia	14
Tonsillectomy	13
	Show More
General Anaesthesia	11
Surgery	10
Maintenance Of Anaesthesia	9
Product Used For Unknown Indication	6
Tongue Tie Operation	2
Sensory Disturbance	2
Appendicectomy	2
Suicide Attempt	2
Haemorrhoid Operation	2
Anaesthesia Procedure	2
Occupational Problem Environmental	1
Dental Caries	1
Facial Bones Fracture	1
Eyelid Ptosis	1
Rotator Cuff Repair	1
Caesarean Section	1
Dental Implantation	1
Wrist Surgery	1
Tooth Repair	1
Dental Care	1
Renal Failure Chronic	1
Cardiac Operation	1
Induction And Maintenance Of Anaest...	1
Sedation	1
Ovarian Operation	1
Ovarian Cancer	1

Drug Labels

Label	Labeler	Effective
Ultane	Abbott Laboratories	04-SEP-12
Ultane	Abbott Laboratories	04-SEP-12

Ultane Case Reports

What Ultane safety concerns are being reported by doctors and researchers in the medical literature?

About Results

This report contains aggregated drug side effects and adverse events for Ultane. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Ultane.